Bowel cancer
Intestinal cancer (carcinoma of rectum) is a common malignant tumor in the gastrointestinal tract. Its incidence rate is second only to stomach and esophageal cancer. It is the most common part of colorectal cancer (accounting for about 60%). The vast majority of patients are over 40 years old, and about 15% are under 30 years old. It is more common in men, with a male-to-female ratio of 2-3:1. Intestinal cancer should be actively prevented.
-
Site of disease:
intestinal -
Infectious :
Not contagious -
Frequent population:
Middle-aged and elderly people -
Related symptoms:
Blood in stool Loss of appetite Weight loss Feeling of incomplete defecation Abnormal bowel movement frequency -
Concurrent disease:
Related Drugs
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:
Haikou Pharmaceutical Factory Co., Ltd.
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:
Beijing SL Pharmaceutical Co., Ltd.
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:
Hubei Ouli Pharmaceutical Co., Ltd.
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:
Hubei Ouli Pharmaceutical Co., Ltd.
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:
Hubei Ouli Pharmaceutical Co., Ltd.
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:
Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd.
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:
Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd.
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:
Yabao Pharmaceutical Group Co., Ltd.